phenylalanyl-prolyl-arginine-chloromethyl ketone has been researched along with Coronary Disease in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 5 (83.33) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Batchelor, WB; Califf, RM; Cantor, WJ; Davidian, M; DiBattiste, PM; Dillard, P; Gretler, D; Harrington, RA; Huang, Y; Larsen, RL; Mantell, RM; Ohman, EM; Sketch, MH; Tcheng, JE; Tolleson, TR; Zhang, D; Zidar, JP | 1 |
Dokainish, H; Gonzales, R; Gonzalez, R; Lakkis, N; Patel, P | 1 |
Proimos, G | 1 |
Eisenberg, PR; Gretler, D; Harrington, RA; Jennings, LK; Joseph, DM; Kleiman, NS; Labinaz, M; Lincoff, AM; McDougal, MF; Potthoff, RF; Tardiff, BE; Vorchheimer, DA | 1 |
Califf, RM; Davidson, CJ; Gilchrist, IC; Grines, CL; Jennings, LK; Kitt, MM; Kleiman, NS; Lincoff, AM; Lorenz, TJ; O'Shea, JC; Talley, JD; Tcheng, JE | 1 |
Ku, DD; Nelson, JM; Winn, MJ | 1 |
1 review(s) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Coronary Disease
Article | Year |
---|---|
Platelet aggregation inhibition with glycoprotein IIb--IIIa inhibitors.
Topics: Abciximab; Adenosine Diphosphate; Amino Acid Chloromethyl Ketones; Antibodies, Monoclonal; Anticoagulants; Clinical Trials as Topic; Coronary Disease; Dose-Response Relationship, Drug; Drug Interactions; Eptifibatide; Heparin; Humans; Immunoglobulin Fab Fragments; Oligopeptides; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Platelet Glycoprotein GPIIb-IIIa Complex; Proteins; Receptors, Thrombin; Thrombin; Tirofiban; Tyrosine | 2001 |
3 trial(s) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Coronary Disease
Article | Year |
---|---|
Randomized COMparison of platelet inhibition with abciximab, tiRofiban and eptifibatide during percutaneous coronary intervention in acute coronary syndromes: the COMPARE trial. Comparison Of Measurements of Platelet aggregation with Aggrastat, Reopro, an
Topics: Abciximab; Acute Disease; Aged; Amino Acid Chloromethyl Ketones; Angina, Unstable; Angioplasty, Balloon, Coronary; Antibodies, Monoclonal; Anticoagulants; Citric Acid; Coronary Disease; Eptifibatide; Female; Humans; Immunoglobulin Fab Fragments; Kinetics; Male; Middle Aged; Myocardial Infarction; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Syndrome; Tirofiban; Tyrosine | 2002 |
Pharmacodynamics and pharmacokinetics of eptifibatide in patients with acute coronary syndromes: prospective analysis from PURSUIT.
Topics: Adenosine Diphosphate; Aged; Amino Acid Chloromethyl Ketones; Angina, Unstable; Antithrombins; Coronary Disease; Eptifibatide; Female; Humans; Male; Middle Aged; Peptide Fragments; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Receptors, Thrombin; Time Factors | 2001 |
Clinical pharmacology of higher dose eptifibatide in percutaneous coronary intervention (the PRIDE study).
Topics: Amino Acid Chloromethyl Ketones; Angioplasty, Balloon, Coronary; Antithrombins; Coronary Disease; Dose-Response Relationship, Drug; Drug Administration Schedule; Eptifibatide; Female; Humans; Male; Metabolic Clearance Rate; Middle Aged; Peptides; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex | 2001 |
2 other study(ies) available for phenylalanyl-prolyl-arginine-chloromethyl ketone and Coronary Disease
Article | Year |
---|---|
Impact of adenosine diphosphate and calcium chelation on platelet aggregation testing in patients receiving clopidogrel therapy.
Topics: Adenosine Diphosphate; Amino Acid Chloromethyl Ketones; Chelating Agents; Citrates; Clopidogrel; Coronary Disease; Cysteine Proteinase Inhibitors; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Platelet Aggregation; Platelet Aggregation Inhibitors; Platelet Function Tests; Sodium Citrate; Ticlopidine | 2006 |
Inhibition of thrombin-induced endothelium-dependent relaxation after coronary ischemia in the dog: possible role of the coagulation cascade.
Topics: 4-Hydroxycoumarins; Acetylcholine; Amino Acid Chloromethyl Ketones; Animals; Blood Coagulation; Calcimycin; Coronary Disease; Dinoprost; Dogs; Endothelium, Vascular; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nitric Oxide; Thrombin | 1991 |